Quanterix Names Jim Gute Interim CEO After Cunningham Exit

Company Quanterix Event Type CEO departure and interim appointment Modality Not applicable (ultrasensitive biomarker diagnostics) Asset Simoa platform Target Not applicable Disease Area Neurology and Alzheimer’s diagnostics Summary Everett Cunningham resigned as Quanterix president, CEO and director effective November 18 to take the CEO role…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *